GSK Can't Escape Classen's Patent Infringement Suit

Law360, New York (May 30, 2012, 8:42 PM EDT) -- A Maryland federal judge on Tuesday refused to dismiss the bulk of a case against GlaxoSmithKline PLC alleging the pharmaceutical giant infringed Classen Immunotherapies Inc.'s patents for evaluating a vaccine immunization schedule, while tossing contributory and willful infringement claims.

U.S. District Judge William D. Quarles Jr. tossed two infringement claims in a suit accusing GSK of violating patents protecting a method of choosing an immunization schedule for infants that lowers the chance of developing chronic immune-mediated disorders or common infectious diseases.

Although Judge Quarles left Classen...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.